Early Phase Cancer Immunotherapy
Description
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
Keywords
MedicalOncology
2017Book
Author(s)Razelle Kurzrock, Sandip Pravin Patel
PublisherSpringer International Publishing
ISBN9783319637563
LanguageEnglish
